Patent ID: 11957736
Assignee: XERIS PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of diagnosing a disease or physical disorder in a human patient suffering from or predisposed to a disease or disorder, the method comprising:
(i) introducing into the patient as an adjunct to a diagnostic test, an effective amount of a stable aprotic polar solvent formulation comprising:
(a) a glucagon peptide, glucagon analog, glucagon mimetic, or salt thereof,
(b) an ionization stabilizing excipient;
(c) an aprotic polar solvent; and
(d) a moisture content from about 25% v/v to about 50% v/v, wherein the formulation is compatible with a container and/or injection device flow path, and

(ii) conducting a diagnostic test on said patient.